ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

MHC Myhealthchecked Plc

12.25
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Myhealthchecked Plc LSE:MHC London Ordinary Share GB00BN7K5L93 ORD 1.5P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.00% 12.25 34,157 00:00:00
Bid Price Offer Price High Price Low Price Open Price
11.50 13.00 12.25 12.25 12.25
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Surgical,med Instr,apparatus 22.31M 1.52M 0.0292 4.20 6.37M
Last Trade Time Trade Type Trade Size Trade Price Currency
14:16:30 O 770 12.46 GBX

Myhealthchecked (MHC) Latest News

Myhealthchecked (MHC) Discussions and Chat

Myhealthchecked Forums and Chat

Date Time Title Posts
28/3/202407:49MyHealthChecked PLC to 100p9,780

Add a New Thread

Myhealthchecked (MHC) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
14:16:3112.4677095.94O
13:43:0012.2932,4623,987.96O
11:27:3111.5366676.79O
10:48:4911.5025929.79O

Myhealthchecked (MHC) Top Chat Posts

Top Posts
Posted at 18/3/2024 07:55 by tia01
After comparing MHC and ABDX you can’t help notice quite a few points.
ABDX market cap over 10m
MHC over 6.5m

ABDX has around 1.9m
MHC has around 8m plus

ABDX has a high cash burn and needed fund raises.

MHC is prudent and cash in the bank growing.

ABDX concentrated on revenue growth.
MHC concentrated on cash flow and growth.

ABDX main product is salistick
MHC has over 20 Products

So is
ABDX Market Cap of 10m justified! Or is MHCs 6.5m way undervalued!

Hopefully end of year results will show growth for MHC and we push up to levels of our competitors to reflect the facts.
Posted at 10/3/2024 20:02 by tia01
I personally feel the last year has been a learning curve MHC to gain information and statistics on the best lines and potential sales in Boots stores and on line.
I also believe MHC is missing an opportunity to get its products in top GYMs etc as this would be direct to potential customers.
Also I feel the share price is at a critical stage on the charts. Either we turn and bounce off current levels or could fall through 12p support.
If the board is serious about growth they need to grow new product sales as Covid product demand recedes. The growth potential and revenue is in the new products 100%
Posted at 02/3/2024 21:33 by tia01
Could ABDX be vulnerable to a takeover given share price keeps falling and the cash burn rate.
They could be potentially be a good fit for MHC who has cash and knowledge of the pregnancy test market which ABDX has developed a great product in. Maybe not a direct takeover but some sort of collaboration. MHC would be able to expand its product base into various places ABDX has established itself due to the salistick it’s developed. This one catching my eye because it’s burning cash whilst concentrating on revenue over profit.
It finance situation makes it a takeover target or a strategic alliance candidate for someone like MHC
Posted at 29/2/2024 22:36 by tia01
Spacedust
Look at avacta and hemo today!
Both doing well until the board decides to kill the price with heavily diluted share price.
Sorry but MHC being extremely well run but equally shares being taken down almost daily.
Only Penny and Chairman buying at these prices would seriously push it higher.
Honestly price is a disaster compared to how well it’s been run.
This is the reason why British companies end up falling when even prudent well run companies get pulled down.
Fundamentals mean nothing on Aim
Posted at 29/2/2024 18:30 by tia01
I’m looking at the Aim and all companies that have fallen to similar lows and percentages as MHC and who need significant funding or had significant dilution are flying.
MHC has great balance sheet,cash in bank and excellent products and still selling covid products. Probably the only company making money from COVID still however the share price equals a market cap less than cash in the bank.
I’m not an accountant but this don’t add up to me.
All we need is a dividend,share buyback or Directors to buy to get this moving back to 20s
Posted at 21/2/2024 19:37 by tia01
Black horse
Without being disrespectful but Money obviously moving to MHC which is why we are 50% up from December roughly.
Given we are on MHC site I’m happy to discuss money inflowing to MHC.
All be it I wish a bit bit quicker lol.
The fact is it’s ticking up without any one noticing it so hopefully a good RNS will come and get MHC noticed.
I do see resistance at 16-17p if we get there as this was the figure around the time we fell early 2023 when the poor figures landed.
I do however feel whilst we have seen a slowdown in covid sales that it’s possible new products are gaining traction.
I do think a explanation as to why some of the good likes like intolerance tests are out of stock for so long online but can only assume that potential buyers will still go to stores nearby or use MHCs site directly.
I feel the next set of results will be a much better set than lasts years. More cash in the bank and I have a sneaky feeling we are probably going to drop news on a few new products in my opinion.
Also need a plan to move more expensive ones otherwise you have to judge if production costs are worth it in the sales figures given they have shelf life expiring dates.
Also is MHC a takeover target with cash situation and no debts.
I just wonder why Directors not buying and wonder if they are excluded because they are privileged to News coming.
All my own personal beliefs but hopefully something soon to take it up to the next level and back to 25p plus as Spacedust said
Posted at 06/2/2024 18:35 by tia01
So that’s 6% of the current shares taken off the market for investing £400,000 from interest which still leaves the company with well over 7.5m to continue its expansion.
The board passed a resolution early in 2023 to be allowed to buy up to 10% of shares back. We could buy back 6% with interest alone. This is a smart way to create investor value and company value with increased share price which increases the power and ability to expand with a higher share price!
Posted at 31/1/2024 11:48 by tia01
Billy
I’m glad your experience was good as mine was also. I’m planning to take more as a middle aged person.

I wish to point out the significance of the role of the pharmacist moving forward given our investor meeting hints by Penny.

The government have said that they expect the 7 new things that pharmacist can prescribe for will free up 10 million new GP appointments!

So based on this how many will MHCs new tests free up and how much in cost saving to the NHS will it save!.

It’s clearly a positive sign that the government are aware that this is the way forward and MHC compliance with all the requirements and digital data suggests they believe it also. This would increase the sales of more expensive tests whilst the basic ones will fly.
Boots in conjunction with MHC have the facilities in place and the benefits to the NHS are clear.
I strongly advise people to revisit the investors meeting and Pick up on Penny’s remarks and also her respect to ensuring she doesn’t divulge Boots plans.
Also our share price is stagnant which is totally annoying but we must remain positive as any RNS and we could see a significant move.
The news today whilst doesn’t directly affect us does point to the way forward and deal with Boots paying dividend shortly.
Posted at 17/1/2024 08:21 by tia01
25% drop in share price from recent highs!
Is it reasonable to say the selling overdone.
Dropped 25% on less than £25,000 worth of shares sold.
So a quarter of the market capital erased.

You can’t make it up.
Extra 2.75m in the bank
£25,000 shares sold in 4 days
Decline in share price 25%.

Sometimes things justify price action and this is clearly one of them times.

I suspect it’s attracting attention at these levels shortly
Posted at 23/12/2023 10:57 by tia01
MHC has the contract to Supply Flowflex to Boots and Lloyds. That’s all so we are the middle person.

The cash in the bank is amazing for a small company and I’m also surprised a larger company ain’t snapped MHC up on a cash shell basis also given they also have over 20 products.
That said Penny is building a stand alone company which is why they are investing in digital data.

2024 could be a great year for MHC if they manage to survive without being taken over.

The thing is what price would someone have to pay. Most investors over 70% down. Mercia own the largest number of shares and wouldn’t accept anything less!!!!.
Remember it went to 7p pre consolidation with a 15-1 consolidation. That’s was with no products. That valued it at £1.10p in today’s market.
They had a share raise which shareholders were excluded from as I believe Mercia etc underwrote it!.
Since then they have 5m in the bank and over 20 products and possibly 7-8m in the bank now and even receiving 5% interest on capital in the bank.
The balance sheet is strong and no need for a cash injection so any buyer would need to pay a premium.
So the question is what is the true valuation!
I would say we get a better picture after Januarys trading update but I suspect 10x current valuation is reasonable if growth can be maintained and new product sales ramped up. Given the potential for ramping up sales such as more contracts,possible deals with GPs etc given HIW and others I potentials like insurance companies and Gyms etc the expansion opportunities are huge. The financial position in a high inflation and interest rate environment is so healthy for MHC they may even make a play for a larger company themselves to expand. They are truly in a perfect place but 2024 is year to truly establish its foothold in the wellbeing market. I’ve used the products and truly believe it’s the way given the NHS is in such a mess.
We also paved the way for dividends!. At these prices I could see any investor in for long term getting dividends equal to share price in ten years if growth goes to plan.
I seen this with Taylor Wimpy when they collapsed to 4p in 2008 and now nearly £1.50p and dividends more than the price in 2008. This is easily foreseeable for MHC but growth projections in next update is key to 2024.
Selling now is suicidal but each to their own and I’m accumulating for a long term and happy to sit tight and regularly top up.
Even though I’m currently down like others it’s about investing not gambling and the figures are satisfying despite blip early 2023. Watch the surprise to the second half catch the markets off gaurd
Myhealthchecked share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock